Search Results - Harald Hampel
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology by Harald Hampel, Harald Hampel, Harald Hampel, Harald Hampel, Edward J. Goetzl, Dimitrios Kapogiannis, Simone Lista, Simone Lista, Simone Lista, Simone Lista, Andrea Vergallo, Andrea Vergallo, Andrea Vergallo, Andrea Vergallo
Published 2019-03-01
Article -
2
-
3
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors by Stefan J. Teipel, Stefan J. Teipel, Enrica Cavedo, Enrica Cavedo, Enrica Cavedo, Enrica Cavedo, Enrica Cavedo, Harald Hampel, Harald Hampel, Harald Hampel, Harald Hampel, Michel J. Grothe, Alzheimer's Disease Neuroimaging Initiative, Alzheimer Precision Medicine Initiative (APMI)
Published 2018-08-01
Article -
4
Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults by Mara ten Kate, Pieter Jelle Visser, Pieter Jelle Visser, Hovagim Bakardjian, Hovagim Bakardjian, Frederik Barkhof, Frederik Barkhof, Sietske A. M. Sikkes, Sietske A. M. Sikkes, Wiesje M. van der Flier, Wiesje M. van der Flier, Philip Scheltens, Harald Hampel, Harald Hampel, Harald Hampel, Harald Hampel, Marie-Odile Habert, Bruno Dubois, Bruno Dubois, Betty M. Tijms
Published 2018-03-01
Article -
5
-
6
-
7
-
8
White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. by Laurence O'Dwyer, Franck Lamberton, Silke Matura, Monika Scheibe, Julia Miller, Dan Rujescu, David Prvulovic, Harald Hampel
Published 2012-01-01
Article -
9
Metabolite profiling of Alzheimer's disease cerebrospinal fluid. by Christian Czech, Peter Berndt, Kristina Busch, Oliver Schmitz, Jan Wiemer, Veronique Most, Harald Hampel, Jürgen Kastler, Hans Senn
Published 2012-01-01
Article -
10
-
11
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis o... by Harald Hampel, Coralie Williams, Adrien Etcheto, Federico Goodsaid, Frédéric Parmentier, Jean Sallantin, Walter E. Kaufmann, Christopher U. Missling, Mohammad Afshar
Published 2020-01-01
Article -
12
No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints by Stefan Teipel, Hovagim Bakardjian, Gabriel Gonzalez-Escamilla, Enrica Cavedo, Sarah Weschke, Martin Dyrba, Michel J. Grothe, Marie-Claude Potier, Marie-Odile Habert, Bruno Dubois, Harald Hampel
Published 2018-01-01
Article -
13
The age-specific comorbidity burden of mild cognitive impairment: a US claims database study by Gang Li, Nicola Toschi, Viswanath Devanarayan, Richard Batrla, Tommaso Boccato, Min Cho, Matteo Ferrante, Feride Frech, James E. Galvin, David Henley, Soeren Mattke, Susan De Santi, Harald Hampel
Published 2023-12-01
Article -
14
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification by Harald Hampel, Simone Lista, Eugeen Vanmechelen, Henrik Zetterberg, Filippo Sean Giorgi, Alessandro Galgani, Kaj Blennow, Filippo Caraci, Brati Das, Riqiang Yan, Andrea Vergallo, for the Alzheimer’s Precision Medicine Initiative (APMI)
Published 2020-10-01
Article -
15
Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment by Patricia Diaz‑Galvan, Giulia Lorenzon, Rosaleena Mohanty, Gustav Mårtensson, Enrica Cavedo, Simone Lista, Andrea Vergallo, Kejal Kantarci, Harald Hampel, Bruno Dubois, Michel J. Grothe, Daniel Ferreira, Eric Westman
Published 2023-10-01
Article -
16
Differential response to donepezil in MRI subtypes of mild cognitive impairment by Patricia Diaz-Galvan, Giulia Lorenzon, Rosaleena Mohanty, Gustav Mårtensson, Enrica Cavedo, Simone Lista, Andrea Vergallo, Kejal Kantarci, Harald Hampel, Bruno Dubois, Michel J. Grothe, Daniel Ferreira, Eric Westman
Published 2023-06-01
Article -
17
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations by Ronald Lautner, Philip S. Insel, Tobias Skillbäck, Bob Olsson, Mikael Landén, Giovanni B. Frisoni, Sanna-Kaisa Herukka, Harald Hampel, Anders Wallin, Lennart Minthon, Oskar Hansson, Kaj Blennow, Niklas Mattsson, Henrik Zetterberg
Published 2017-10-01
Article -
18
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's disease. by Gregory Penner, Soizic Lecocq, Anaëlle Chopin, Ximena Vedoya, Simone Lista, Andrea Vergallo, Enrica Cavedo, Francois-Xavier Lejeune, Bruno Dubois, Harald Hampel, INSIGHT-preAD study group, Alzheimer Precision Medicine Initiative (APMI)
Published 2021-01-01
Article -
19
-
20
Sexual dimorphism in healthy aging and mild cognitive impairment: a DTI study. by Laurence O'Dwyer, Franck Lamberton, Arun L W Bokde, Michael Ewers, Yetunde O Faluyi, Colby Tanner, Bernard Mazoyer, Desmond O'Neill, Máiréad Bartley, Rónán Collins, Tara Coughlan, David Prvulovic, Harald Hampel
Published 2012-01-01
Article